Local News: Canyon Lake, TX 

 | 

Sign Up

 | 

Sign In

Advertisment

VIVUS News Editors

RoboBlogger

I edit this news page on Topix when no humans are available to help.

People just like you make VIVUS News on Topix better every day. If you're interested in becoming an editor, apply today!

Edits History | Editor Blog

RSS icon mobile icon

VIVUS News

News on VIVUS continually updated from thousands of sources around the net.

8 hrs ago | Optionetics

Option Watch: Dec 16, Ho-ho-hopeful or Just Fast Money in VVUS?

Tuesday saw what this strategist likes to affectionately call the latest serving of "takeover chowder" and what many other traders call the rumor mill.

Comment?

Related Topix: Biotech, Medical Equipment, Medicine, Healthcare Industry

Mon Nov 23, 2009

The Motley Fool

The Side Effect of Developing Obesity Drugs

Abbott Labs ' Meridia is supposed to make patients healthier by helping them lose weight, but it looks like it's having the opposite effect in some patients.

Comment?

Related Topix: Biotech, Abbott Laboratories, Food and Drug Administration, Medicine, Medical Equipment, Healthcare Industry, Arena Pharmaceuticals

MarketWatch

Drug stocks mixed; Vivus jumps on study

Nyse Arca Biotechnology Inde /marketstate/country/ 9:52:11 am 9:52:11 am 887.14 Change -9.65 -1.08% Volume 0.00 $BTK Kiosk Intraday data provided by Interactive Data Real Time Services , a division of Interactive Data Corp.

Comment?

Related Topix: Biotech, Medicine, Medical Equipment, Healthcare Industry, Media, Interactive Data, Computers, IT Services, Dow Jones , Publishing

Sat Nov 21, 2009

Minyanville

Obesity and ED: Two Big Markets, One Tiny Company

Vivus is raising the bar on erectile dysfunction drugs, potentially becoming the latest formidable competitor to Viagra and Cialis in the $3.8 billion market.

Comment?

Related Topix: Biotech, Medicine, Medical Equipment, Healthcare Industry, Erectile Dysfunction, Health, Pfizer, Eli Lilly, Healthcare Law, Law, Texas

Thu Nov 19, 2009

Bloomberg

Vivus Erection Drug Avanafil Helps Men in 30 Minutes, Company Study Says

Vivus Inc ., an unprofitable biotechnology company, said its experimental impotence drug helped men in a study achieve erections in 30 minutes.

Comment?

Related Topix: Biotech, Medicine, Medical Equipment, Healthcare Industry, Erectile Dysfunction, Health, Pfizer, Eli Lilly, Indianapolis, IN, Indianapolis Metro

Drugs.com

VIVUS Announces Positive Results From Phase 3 Study of Avanafil in...

VIVUS, Inc. today announced positive results from REVIVE , a phase 3 pivotal study evaluating the safety and efficacy of avanafil, an investigational drug candidate for the treatment of erectile dysfunction , in 646 patients.

Comment?

Related Topix: Biotech, Medicine, Medical Equipment, Healthcare Industry, Startups, VIVUS, Erectile Dysfunction, Health, Healthcare Law, Food and Drug Administration, Law

Fox News

Vivus Shares Rise on Erectile Dysfunction Drug Success

Vivus Inc. shares rose Wednesday on news that its erectile dysfunction drug was effective in a late stage trial, putting the biotech firm on course to file an application with the Food and Drug Administration in 2011.

Comment?

Related Topix: Biotech, Medicine, Medical Equipment, Healthcare Industry, Erectile Dysfunction, Health, Healthcare Law, Law, Business News

Wed Nov 18, 2009

The South Mississippi Sun Herald

Coventry, BJ's Wholesale, Vivus are big movers

The following stocks were among those that moved substantially or traded heavily Wednesday on the New York Stock Exchange: NYSE: Coventry Health Care Inc., down 63 cents at $23.05 An analyst said the health insurer will likely offer a disappointing 2010 earnings outlook and may be hit hard by health care reforms.

Comment?

Related Topix: Biotech, Medicine, Medical Equipment, Coventry Health Care, Healthcare Industry, Financial Markets, Manufacturing, Industrial Machines, Security, United Technologies Corporation, Oil & Gas, Smith International, Energy, Retail, BJs Wholesale Club

The Motley Fool

VIVUS Gets a Spark

VIVUS has been plodding along over the past decade, but after a pair of successful clinical trials for its weight-loss drug, Qnexa, the company is now getting some good clinical trial data for erectile-dysfunction drug avanafil .

Comment?

Related Topix: Biotech, Medicine, Medical Equipment, Healthcare Industry, Startups, VIVUS, Erectile Dysfunction, Health, Eli Lilly, Merck , GlaxoSmithKline

Indianapolis Star

Rival: ED drug faster than Viagra, Lilly's Cialis

A drug being developed by a California company was shown in a trial to be effective in 30 minutes or less, much faster than its competitors, the maker of treatments for erectile dysfunctions said today.

Comment?

Related Topix: Viagra, Sildenafil (generic), Medicine, Medication, Erectile Dysfunction, Health, Biotech, Medical Equipment, Healthcare Industry, Indianapolis, IN, Indianapolis Metro, Eli Lilly

MarketWatch

After Hours: Salesforce, Autodesk shares struggle in late trade

Autodesk Inc. shares dropped nearly 10% Tuesday evening after the design software maker provided a soft operating-margin forecast.

Comment?

Related Topix: Autodesk, Computer-Aided Design, Manufacturing and Engineering, Software, Startups, Salesforce.com, salesforce.com, Biotech, Medicine, Medical Equipment, Healthcare Industry

Sat Nov 07, 2009

American Chronicle

News and FDA Updates for Isis

A complete list of all headlines and biomedical stock developments can be found on BioMedReports.Com On 11/05/09, Isis Pharmaceuticals, Inc.

Comment?

Related Topix: Healthcare Law, Law, Biotech, Isis Pharmaceuticals, Food and Drug Administration, Medicine, Healthcare Industry, Medical Equipment, Startups, VIVUS, Opinion

Fri Nov 06, 2009

Earth Times

MSTR, VVUS, BARE were Today's Top Small-Cap Movers on NASDAQ as Reported by PennyStockPickAlert.com

Dallas, TX - MicroStrategy Incorporated was one of the most active gainers as it rallied over 18.83% to close at $87.27 on huge volume of 1.50 million shares after the company yesterday announced financial results for the three-month period ended September 30, 2009.

Comment?

Related Topix: Dallas, TX, Dallas Metro, MicroStrategy, Software, Biotech, Medicine, Medical Equipment, Healthcare Industry, Startups, VIVUS, Financial Markets

Wed Nov 04, 2009

Bizjournals

Vivus names Peter Tam president

Vivus Inc. on Tuesday named Peter Tam president, taking over the role from Leland Wilson.

Comment?

Related Topix: Startups, VIVUS, Biotech, Medicine, Medical Equipment, Healthcare Industry

Tue Nov 03, 2009

East Bay Business Times

Vivus promotes COO to president

Vivus Inc. promoted Peter Tam, its chief operating officer, to president. That title was held previously by CEO Leland Wilson, who will now be just CEO.

Comment?

Related Topix: Biotech, Medicine, Medical Equipment, Healthcare Industry, Startups, Xoma

Mon Nov 02, 2009

TheStreet.com

Amylin Strikes First With Obesity Drug Deal: BioBuzz

Investors are waiting for big obesity drug marketing deals from Vivus , Arena Pharmaceuticals and Orexigen Therapeutics , yet the first pact signed Sunday night comes from Amylin Pharmaceuticals ?!?! It's actually not that much of a surprise.

Comment?

Related Topix: Biotech, Medicine, Amylin Pharmaceuticals, Healthcare Industry, Medical Equipment, Marketing, Arena Pharmaceuticals, Healthcare Law, Law

Sun Nov 01, 2009

Fox News

Early-Market Movers: Genworth, Ruth's

Futures were in the red Friday morning coming off Thursdaya s 200-point rally as traders work through personal income and spending numbers and wait for consumer sentiment data and Chicago PMI releases.

Comment?

Related Topix: AXT, Semiconductors, Electronics, Biotech, Medicine, Medical Equipment, Healthcare Industry, Healthcare Law, Law, Business News

Fri Oct 30, 2009

M2.com

VIVUS announces data from Qnexa Phase III studies at The Obesity...

VIVUS announces data from Qnexa Phase III studies at The Obesity Society 27th annual scientific meeting Published in M2Europharma on Friday, 30 October 2009 at 21:38 GMT 30 October 2009 - US-based biopharmaceutical company VIVUS Inc today announced that additional data on Qnexa, an investigational drug candidate for obesity, was presented at the ...

Comment?

Related Topix: Biotech, Medicine, Medical Equipment, Healthcare Industry, Startups, VIVUS

SchaeffersResearch.com Daily Market Blog

Drug Data Draws Call Traders to VIVUS, Inc.

More specifically, the biopharmaceutical firm gave an upbeat update on the late-stage study of experimental weight-loss drug Qnexa.

Comment?

Related Topix: Biotech, Medicine, Medical Equipment, Healthcare Industry, Day Trading, Financial Markets, Personal Finance

Thu Oct 29, 2009

PR-inside.com

PicksThatMove.com Announces Investment Opinion on ARNA, MRVL, VVUS, NET and TSM

PicksThatMove is pleased to bring investors special situation stocks which have a high potential for price appreciation.

Comment?

Related Topix: Semiconductors, Financial Markets, Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals, Marvell Technology Group, Electronics, Medical Equipment, Startups, VIVUS, Opinion

Canyon Lake Jobs

Also on Topix